| 영문 | suicide | 한글 | 자살 |
|---|---|---|---|
| 설명 | 스스로 자신의 목숨을 끊음. 즉, 행위자가 자신의 죽음을 초래할 의도를 가지고 자신의 생명을 끊는 행위. 자살의 영어대응어인 suicide의 어원은 라틴어의 sui(자기 자신을)와 caedo(죽이다)의 두 낱말의 합성어이다. 여기서 알 수 있듯이, 자살이란 그 원인이 개인적이든 사회적이든, 당사자가 자유의사에 의하여 자신의 목숨을 끊는 행위를 말한다. 이 정의는 일견 명백하기는 하나 실제로는 여러 문제가 있다. 자살의 원인은 복잡하고 파악하기 어려운데, 통계에 의하면 신경쇠약-실연-병고-생활고-가정불화-장래에 대한 고민-사업실패-염세 등 여러 가지가 있으며, 그 중에서도 염세-병고-신경쇠약-실연-가정불화가 두드러지게 많다. 이것을 남녀별로 보면 남자에게는 신경쇠약과 병고가 많고, 여자에게는 가정불화와 실연이 많다. 그리고 연령별로는 청소년에서는 실연과 염세가 많고, 노인에서는 병고가 특징적으로 많다. 가정불화는 20~30대에 많다. |
||
| BPTI | basic pancreatic trypsin inhibitor; basic polyvalent trypsin inhibitor; bovine pancreatic trypsin in... |
|---|---|
| PI | first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;... |
| MSDI | Martin Suicide Depression Inventory |
| PAS | para aminosalicylate; Parent Attitude Scale; patient administration system; patient appointments and... |
| SA | salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame... |
| PAS | Physician assisted suicide |
|---|---|
| ACE inhibitor | angiotensin converting enzyme inhibitor |
| CPI | 1-cysteine proteinase inhibitor |
| PIC | 1-plasmin inhibitor complex |
| PAI-1 | Plaminogen Activator Inhibitor-1 |
| suicide | The act of killing oneself. (12 Dec 1998) |
|---|---|
| suicide, assisted | Deliberate acceleration of death of a competent patient with an incurable disease or in the extremes of suffering. The patient seeking assistance in taking his own life may ask the help of a physician or other health professional, a family member, or a friend. The milieu may be a hospital, nursing home, or private residence. Assistance to the person in dire physical or psychological distress may take the form of lethal doses of medications or chemicals to be taken orally or by injection through human intervention or with a so-called suicide machine. (12 Dec 1998) |
| suicide, attempted | The unsuccessful attempt to kill oneself. (12 Dec 1998) |
| suicide substrate | A competitive inhibitor that is converted to an irreversible inhibitor at the active site of the enzyme. Synonym: mechanism-based inhibitor. (05 Mar 2000) |
| a1-trypsin inhibitor | A glycoprotein that is the major protease inhibitor of human serum, is synthesised in the liver, and is genetically polymorphic due to the presence of over 20 alleles; individuals appropriately homozygous are deficient in a1-trypsin and are predisposed to pulmonary emphysema and juvenile hepatic cirrhosis because of alterations in the amino acid and sialic acid components of the glycoprotein. A1-Antitrypsin also inhibits thrombin. Synonym: a1-trypsin inhibitor, human a1-proteinase inhibitor. (05 Mar 2000) |
| ACE inhibitor | <pharmacology> A group of antihypertensive medications that work by inhibiting an enzyme (angiotensin-converting enzyme) that is important in the regulation of blood pressure. Studies have also indicated that it may help prevent or slow the progression of kidney disease in patients with diabetes. Examples include: captopril, ramipril, enalapril, losartan potassium, bepridil and lisinopril. (12 Mar 1998) |
| aldose reductase inhibitor | <pharmacology> A class of drugs being studied as a way to prevent eye and nerve damage in people with diabetes. Aldose reductase is an enzyme that is normally present in the eye and in many other parts of the body. It helps change glucose (sugar) into a sugar alcohol called sorbitol. Too much sorbitol trapped in eye and nerve cells can damage these cells, leading to retinopathy and neuropathy. Drugs that prevent or slow (inhibit) the action of aldose reductase are being studied as a way to prevent or delay these complications of diabetes. (09 Oct 1997) |
| angiotensin-converting enzyme inhibitor | <pharmacology> A class of drugs used in the treatment of hypertension and heart failure. They exert their haemodynamic effect mainly by inhibiting the renin-angiotensin system and produce a reduction of peripheral arterial resistance. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (14 Aug 2000) |
| aromatase inhibitor | Drugs, such as aminoglutethimide, that inhibit aromatase, an enzyme used in the synthesis of oestrogens. (05 Mar 2000) |
| beta-lactamase inhibitor | <pharmacology> Drugs such as clavulanic acid, which are used to inhibit bacterial beta-lactamases; often used with a penicillin or cephalosporin to overcome drug resistance. (05 Mar 2000) |
| Bowman-Birk inhibitor | A polypeptide that will inhibit both trypsin and chymotrypsin. (05 Mar 2000) |
| C1 esterase inhibitor | An a2-neuraminoglycoprotein that inhibits the enzymatic activity of C1 esterase, the activated first component of complement. A deficiency of this inhibitor results in a lack of inhibition of C1r and C1s leading to uncontrolled activation of the complement cascade and oedema. (05 Mar 2000) |
| carbonate dehydratase inhibitor | An agent, usually chemically related to the sulfonamides, that inhibits the activity of carbonate dehydratase, producing a general decrease in the formation of H2CO3 in the tissues. See: acetazolamide, dichlorphenamide. Synonym: carbonic anhydrase inhibitor. (05 Mar 2000) |
| carbonic acid inhibitor | <pharmacology> A group of diuretic medications which act to inhibit the enzyme carbonic anhydrase to create a metabolic acidosis. Many of these medications are used in the treatment of glaucoma. (27 Sep 1997) |
| carbonic anhydrase inhibitor | <pharmacology> A group of medications (sulphonamide drugs) which inhibit the enzyme carbonic anhydrase. These medications are used in the treatment of glaucoma. Examples include acetazolamide, dichlorphenamide and methazolamide. (27 Sep 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|